Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Techno9 Indonesia Tbk. (NINE)

UBC Medical Indonesia Tbk.Trading
Techno9 Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Techno9 Indonesia Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp162 (kapitalisasi pasar 635,95 M, volume 24 jam 217,8 rb), sedangkan Techno9 Indonesia Tbk. diperdagangkan di Rp78 (kapitalisasi pasar 168,25 M, volume 24 jam 2,11 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 3,8× kapitalisasi pasar Techno9 Indonesia Tbk., dan Techno9 Indonesia Tbk. lebih aktif diperdagangkan (2,11 jt vs 217,8 rb). Mana yang lebih baik tergantung tujuan investasimu.

LABSNINE
Kapitalisasi Pasar
635,95 M168,25 M
Volume
217,8 rb2,11 jt
Lot
2,18 rb21,13 rb
Perputaran
35,43 jt164,55 jt
Harga Rata-rata
162,6977,9
Nilai Transaksi
35,43 jt164,55 jt
Harga Ekuilibrium Indikatif
163
Volume Ekuilibrium Indikatif
16

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
NINE
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Techno9 Indonesia Tbk.

PT Techno9 Indonesia,Tbk (the"Company")wasestablished based on Deed No. 05 dated June 9, 2010, whichwasmade before Notary Lidya Enywati Tjendra, S.H. The Company started its commercial operations since June 23, 2010

Selengkapnya di halaman NINE